"Sumatriptan" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
| Descriptor ID |
D018170
|
| MeSH Number(s) |
D02.065.884.750 D02.886.590.700.750 D03.633.100.473.914.907
|
| Concept/Terms |
Sumatriptan- Sumatriptan
- 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide
|
Below are MeSH descriptors whose meaning is more general than "Sumatriptan".
Below are MeSH descriptors whose meaning is more specific than "Sumatriptan".
This graph shows the total number of publications written about "Sumatriptan" by people in this website by year, and whether "Sumatriptan" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sumatriptan" by people in Profiles.
-
Silberstein SD, Newman LC, Marmura MJ, Nahas SJ, Farr SJ. Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from pain. Curr Med Res Opin. 2013 Jul; 29(7):861-7.
-
Marmura MJ, Pello SJ, Young WB. Interictal pain in cluster headache. Cephalalgia. 2010 Dec; 30(12):1531-4.
-
Nahas SJ, Silberstein SD. Triptans: actions and reactions. Headache. 2008 Apr; 48(4):611-3.
-
Moss HB, Hardie TL, Dahl JP, Berrettini W, Xu K. Diplotypes of the human serotonin 1B receptor promoter predict growth hormone responses to sumatriptan in abstinent alcohol-dependent men. Biol Psychiatry. 2007 Apr 15; 61(8):974-8.
-
Lofland JH, Nash DB. Oral serotonin receptor agonists: a review of their cost effectiveness in migraine. Pharmacoeconomics. 2005; 23(3):259-74.
-
Rubinstein J, Moghe R, Mizrachi A, Dissin J. Triptan use preceding life-threatening arrhythmias in charcot-marie-tooth: a case report and review of the literature. Clin Neuropharmacol. 2004 Jan-Feb; 27(1):14-6.
-
Lofland JH, Kim SS, Batenhorst AS, Johnson NE, Chatterton ML, Cady RK, Kaniecki R, Nash DB. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine. Mayo Clin Proc. 2001 Nov; 76(11):1093-101.
-
Lofland JH, Johnson NE, Batenhorst AS, Nash DB. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective. Arch Intern Med. 1999 Apr 26; 159(8):857-63.